Brief: Fusion Pharmaceuticals reports Q2 results
09/08/2022 13:02
Aug 9 (Reuters) - Fusion Pharmaceuticals Inc FUSN.O :
* FOR Q2 OF 2022, FUSION REPORTED A NET LOSS OF $19.1
MILLION, OR
$0.44 PER SHARE
* AS OF JUNE 30, 2022, FUSION HELD CASH, CASH EQUIVALENTS
AND
INVESTMENTS OF $198.4 MILLION
* FUSION PHARMACEUTICALS - EXPECTS EXISTING CASH, CASH
EQUIVALENTS
AND INVESTMENTS AS OF JUNE 30, 2022, SUFFICIENT TO FUND
OPERATIONS INTO Q1 OF 2024
* Q2 EARNINGS PER SHARE VIEW $-0.53 -- REFINITIV IBES DATA
Source text for Eikon: ID:nCNWJPhk1a
Further company coverage: FUSN.O
Recent news on Fusion Pharmaceuticals
See all newsBrief: Acquisition Of Fusion Pharmaceuticals Completed
Brief: Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary